|
Country
|
Funding Sources
|
|
Argentina
|
INCLEN, CURE
|
|
Australia
|
CURE
|
|
Bahrain
|
Servier Les Laboratories
|
|
Botswana
|
Astra South Africa
|
|
Brazil
|
CURE
|
|
Cameroon
|
INCLEN
|
|
Canada
|
CURE
|
|
Chile
|
INCLEN, Universidad de la Frontera, Sociedad Chilena de Cardiologia Filial Sur
|
|
Columbia
|
Colciencias, Ministerio de Salud
|
|
Croatia
|
Croatian Ministry of Science & Technology
|
|
Czech Republic
|
CURE
|
|
Germany
|
CURE
|
|
Greece
|
CURE
|
|
Guatemala
|
Liga Guatemalteca del Corazon, AVENTIS Guatemala
|
|
Hungary
|
ASTRA Hassle, National Health Science Council, CURE
|
|
IRAN
|
Iran Ministry of Health, Iranian Tobacco Company
|
|
Israel
|
CURE
|
|
Italy
|
CURE
|
|
Japan
|
Sankyo Pharmaceutical Co., Merck Japan, Astra Japan
|
|
Kuwait
|
Endowment Fund for Health Development in Kuwait
|
|
Mexico
|
CURE, INCLEN
|
|
Netherlands
|
CURE
|
|
Philippines
|
Philippine Council for Health Research & Dev., INCLEN, Pfizer Philippines Foundation Inc., Astra Pharmaceuticals (Philippines) Inc, & the Astra Fund for Clinical Research & Continuing Medical Education, Pharmacia & Upjohn Inc.
|
|
Poland
|
CURE
|
|
Portugal
|
CURE
|
|
Singapore
|
Singapore National Heart Association
|
|
South Africa
|
MRC South Africa, Parke-David Pharmaceuticals, Aventis, CURE
|
|
Spain
|
CURE
|
|
Sweden
|
Grant from the Swedish State under LUA Agreement
|
|
Thailand
|
INCLEN
|
|
U.S.A.
|
CURE, King Pharmaceuticals
|
|
United Kingdom
|
CURE
|
|
Zimbabwe
|
INCLEN
|